CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-01 | HOLLER FRANK A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-01 | PIMSTONE SIMON N. CEO | Sale | −3,000 | $14.43 | $43K | 255,186 |
| 2020-05-29 | HOLLER FRANK A Director | Exercise or conversion | +3,086 | $3.56 | $11K | 122,041 |
| 2020-05-29 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2020-05-29 | PIMSTONE SIMON N. CEO | Sale | −5,000 | $13.99 | $70K | 258,186 |
| 2020-05-26 | PIMSTONE SIMON N. CEO | Exercise or conversion | +6,172 | $3.56 | $22K | 264,294 |
| 2020-05-26 | PIMSTONE SIMON N. CEO | Shares withheld for taxes | −1,108 | $14.90 | $17K | 263,186 |
| 2020-05-26 | PIMSTONE SIMON N. CEO | Exercise or conversion · Stock Option (Right to Buy) | −6,172 | 0 | ||
| 2020-03-12 | EMPFIELD JAMES R. SVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-03-12 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-03-12 | AYCARDI-FONSECA ERNESTO CMO | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-03-12 | MORTIMER IAN PRESIDENT & CFO | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2020-03-12 | PIMSTONE SIMON N. CEO | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2020-01-13 | Desjardins Clarissa Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-12-16 | AZAB MOHAMMAD Director | Exercise or conversion | +3,086 | $3.56 | $11K | 60,647 |
| 2019-12-16 | AZAB MOHAMMAD Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2019-12-04 | PATOU GARY Director | Exercise or conversion | +2,057 | $3.56 | $7K | 21,516 |
| 2019-12-04 | PATOU GARY Director | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2019-11-21 | TARNOW MICHAEL M Director | Exercise or conversion | +5,144 | $3.56 | $18K | 69,713 |
| 2019-11-21 | TARNOW MICHAEL M Director | Gift | −5,144 | 64,569 |
Page 23 of 27 · 536 trades